<DOC>
	<DOC>NCT02229045</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness and safety of albumin bound paclitaxel plus 5-FU and as second-line therapy in the treatment of taxanes naive patients with advanced gastric cancer.</brief_summary>
	<brief_title>Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Taxane</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histologically confirmed adenocarcinoma of the stomach with inoperable locally advanced or recurrent and/or metastatic disease. Male or female. Age 18 75. Previous one line of nontaxane chemotherapy for advanced/metastatic disease. Measurable disease, according to the Response Evaluation Criteria in Solid Tumours(RECIST) ECOG Performance status 0, 1 or 2 Haematological, Biochemical and Organ Function: Neutrophil count &gt;2.0 × 10 9/L, platelet count &gt; 100 ×10 9/L. Serum bilirubin&lt; 1.5 × upper limit of normal (ULN); or, AST or ALT &lt; 2.5 × ULN (or &lt; 5 × ULN in patients with liver metastases); or, alkaline phosphatase&lt; 2.5 × ULN (or &gt; 5 × ULN in patients with liver metastases,Creatinine clearance &gt; 60 mL/min. Signed informed consent. No prior chemotherapy for gastric cancer. Received any investigational drug treatment within 30 days of start of study treatment. Patients with active gastrointestinal bleeding. Neurological toxicity ≥ grade 2 NCICTCAE. Other malignancy within the last 5 years, except for carcinoma in situ of the cervix, or basal cell carcinoma. History or clinical evidence of brain metastases. Serious uncontrolled systemic intercurrent illness, e.g. infections or poorly controlled diabetes. Pregnancy women. Subjects with reproductive potential not willing to use an effective method of contraception. Patients with known active infection with HIV. Known hypersensitivity to any of the study drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>gastric caner</keyword>
	<keyword>Albumin Bound Paclitaxel</keyword>
	<keyword>5-FU/CF</keyword>
	<keyword>taxanes naive</keyword>
</DOC>